Skip to main content
Premium Trial:

Request an Annual Quote

OGT, Agilent Partner on Microarray Development

NEW YORK (GenomeWeb News) - Oxford Gene Technology said today that it has inked a collaborative agreement with Agilent Technologies that gives it access to Agilent’s microarray platform and makes Agilent an OEM supplier of OGT-designed microarrays.
 
Under the deal, OGT becomes an Agilent certified service provider and the companies plan to create a “Center of Microarray Excellence” that will focus on emerging microarray applications, such as array-CGH, ChIP-onchip, methylation, and microRNA analysis.   
 
OGT said it will use Agilent’s 2100 Bioanalyzer platform and GeneSpring microarray analysis software in the center.
 
The agreement follows a number of licensing agreements that OGT has recently signed with MassTag Technologies, NimbleGen, and Illumina.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.